Skip to main content
Fig. 2 | Cardiovascular Diabetology

Fig. 2

From: Metabolic syndrome in patients with type 2 diabetes and atherosclerotic cardiovascular disease: a post hoc analyses of the EMPA-REG OUTCOME trial

Fig. 2

Association of metabolic syndrome at baseline and outcomes in the placebo group (patients without metabolic syndrome is reference group). *Excluding fatal stroke. Cox models include terms for baseline age, sex, HbA1c, eGFR, geographical region, treatment, MetS at baseline and treatment*MetS at baseline interaction. CV cardiovascular, HHF hospitalization for heart failure, MetS metabolic syndrome

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840